General Catalyst

Activity from announced rounds

Activity in this selectionBiotech

General Catalyst backs companies from formation and seed through growth, and also creates businesses with founders through its Creation strategy.

Creation includes starting companies in complex or emerging industries, helping experienced founders launch again and combining existing service businesses with applied AI. That makes GC relevant both to founders raising for an established startup and to entrepreneurs developing a new company with an investment partner.

For businesses that have reached product-market fit, its Customer Value Fund provides a separate way to finance customer acquisition. This sits alongside seed and growth equity, giving the firm a financing model directed specifically at the cost of expanding a customer base.

Sources
Rounds participated in
6
Confirmed lead rounds
0
5 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$803M
6 disclosed · full round size, not this investor’s share

By stage

Seed2
Series C+2
Series A1
Series B1

By primary sector

Biotech5
Healthtech1

By country

United States6

Rounds

6 in this selection
Evvy

Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.

$40MSeries B
Participant
Transfyr

Physical AI platform capturing real-world lab science into machine-readable data

$25MSeed
Role not disclosed
Chai Discovery

Building AI models to accelerate pre-clinical drug discovery

$400MSeries C
Role not disclosed
Waypoint Bio

Develops AI-designed CAR T therapies for solid tumors using spatial biology

$20MSeries A
Role not disclosed
ParcelBio

Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology

$13MSeed
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed